LYONDELLBASELL INDU-CL A (LYB) Fundamental Analysis & Valuation

NYSE:LYB • NL0009434992

66.643 USD
+4.72 (+7.63%)
Last: Mar 5, 2026, 11:15 AM

This LYB fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to LYB. LYB was compared to 83 industry peers in the Chemicals industry. Both the profitability and financial health of LYB have multiple concerns. LYB has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. LYB Profitability Analysis

1.1 Basic Checks

  • In the past year LYB was profitable.
  • In the past year LYB had a positive cash flow from operations.
  • Of the past 5 years LYB 4 years were profitable.
  • Each year in the past 5 years LYB had a positive operating cash flow.
LYB Yearly Net Income VS EBIT VS OCF VS FCFLYB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B

1.2 Ratios

  • The Return On Assets of LYB (-2.21%) is worse than 61.45% of its industry peers.
  • LYB's Return On Equity of -7.46% is on the low side compared to the rest of the industry. LYB is outperformed by 63.86% of its industry peers.
  • LYB has a Return On Invested Capital of 2.51%. This is in the lower half of the industry: LYB underperforms 61.45% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for LYB is in line with the industry average of 6.36%.
  • The 3 year average ROIC (6.66%) for LYB is well above the current ROIC(2.51%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -2.21%
ROE -7.46%
ROIC 2.51%
ROA(3y)2.42%
ROA(5y)6.64%
ROE(3y)6.57%
ROE(5y)19.56%
ROIC(3y)6.66%
ROIC(5y)11.12%
LYB Yearly ROA, ROE, ROICLYB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

1.3 Margins

  • Looking at the Operating Margin, with a value of 2.76%, LYB is doing worse than 65.06% of the companies in the same industry.
  • LYB's Operating Margin has declined in the last couple of years.
  • The Gross Margin of LYB (8.55%) is worse than 83.13% of its industry peers.
  • In the last couple of years the Gross Margin of LYB has declined.
Industry RankSector Rank
OM 2.76%
PM (TTM) N/A
GM 8.55%
OM growth 3Y-35.45%
OM growth 5Y-18.61%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.25%
GM growth 5Y-6.92%
LYB Yearly Profit, Operating, Gross MarginsLYB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15 20

3

2. LYB Health Analysis

2.1 Basic Checks

  • LYB has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for LYB has been reduced compared to 1 year ago.
  • Compared to 5 years ago, LYB has less shares outstanding
  • LYB has a worse debt/assets ratio than last year.
LYB Yearly Shares OutstandingLYB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
LYB Yearly Total Debt VS Total AssetsLYB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • LYB has an Altman-Z score of 1.92. This is not the best score and indicates that LYB is in the grey zone with still only limited risk for bankruptcy at the moment.
  • LYB's Altman-Z score of 1.92 is in line compared to the rest of the industry. LYB outperforms 51.81% of its industry peers.
  • LYB has a debt to FCF ratio of 33.69. This is a negative value and a sign of low solvency as LYB would need 33.69 years to pay back of all of its debts.
  • With a Debt to FCF ratio value of 33.69, LYB perfoms like the industry average, outperforming 44.58% of the companies in the same industry.
  • LYB has a Debt/Equity ratio of 1.22. This is a high value indicating a heavy dependency on external financing.
  • LYB's Debt to Equity ratio of 1.22 is on the low side compared to the rest of the industry. LYB is outperformed by 71.08% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.22
Debt/FCF 33.69
Altman-Z 1.92
ROIC/WACC0.33
WACC7.61%
LYB Yearly LT Debt VS Equity VS FCFLYB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.3 Liquidity

  • A Current Ratio of 1.77 indicates that LYB should not have too much problems paying its short term obligations.
  • The Current ratio of LYB (1.77) is comparable to the rest of the industry.
  • A Quick Ratio of 1.20 indicates that LYB should not have too much problems paying its short term obligations.
  • LYB has a Quick ratio (1.20) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.77
Quick Ratio 1.2
LYB Yearly Current Assets VS Current LiabilitesLYB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

3

3. LYB Growth Analysis

3.1 Past

  • LYB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -73.44%.
  • Measured over the past years, LYB shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -21.44% on average per year.
  • LYB shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -25.18%.
  • The Revenue has been growing slightly by 1.67% on average over the past years.
EPS 1Y (TTM)-73.44%
EPS 3Y-48.49%
EPS 5Y-21.44%
EPS Q2Q%-134.67%
Revenue 1Y (TTM)-25.18%
Revenue growth 3Y-15.77%
Revenue growth 5Y1.67%
Sales Q2Q%-25.33%

3.2 Future

  • Based on estimates for the next years, LYB will show a very strong growth in Earnings Per Share. The EPS will grow by 48.11% on average per year.
  • Based on estimates for the next years, LYB will show a decrease in Revenue. The Revenue will decrease by -0.68% on average per year.
EPS Next Y58.88%
EPS Next 2Y51.34%
EPS Next 3Y45.54%
EPS Next 5Y48.11%
Revenue Next Year-1.35%
Revenue Next 2Y-0.34%
Revenue Next 3Y0.86%
Revenue Next 5Y-0.68%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
LYB Yearly Revenue VS EstimatesLYB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B 40B 50B
LYB Yearly EPS VS EstimatesLYB Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5 10 15

4

4. LYB Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 39.20, which means the current valuation is very expensive for LYB.
  • The rest of the industry has a similar Price/Earnings ratio as LYB.
  • Compared to an average S&P500 Price/Earnings ratio of 27.03, LYB is valued a bit more expensive.
  • A Price/Forward Earnings ratio of 24.67 indicates a rather expensive valuation of LYB.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of LYB is on the same level as its industry peers.
  • LYB's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 25.11.
Industry RankSector Rank
PE 39.2
Fwd PE 24.67
LYB Price Earnings VS Forward Price EarningsLYB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as LYB.
  • LYB's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 55.88
EV/EBITDA 13.15
LYB Per share dataLYB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as LYB's earnings are expected to grow with 45.54% in the coming years.
PEG (NY)0.67
PEG (5Y)N/A
EPS Next 2Y51.34%
EPS Next 3Y45.54%

6

5. LYB Dividend Analysis

5.1 Amount

  • LYB has a Yearly Dividend Yield of 4.90%, which is a nice return.
  • LYB's Dividend Yield is rather good when compared to the industry average which is at 2.19. LYB pays more dividend than 90.36% of the companies in the same industry.
  • LYB's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 4.9%

5.2 History

  • The dividend of LYB has a limited annual growth rate of 5.33%.
  • LYB has paid a dividend for at least 10 years, which is a reliable track record.
  • The dividend of LYB decreased recently.
Dividend Growth(5Y)5.33%
Div Incr Years1
Div Non Decr Years1
LYB Yearly Dividends per shareLYB Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6 8

5.3 Sustainability

  • LYB has negative earnings and hence a negative payout ratio. The dividend may be in danger.
  • The dividend of LYB is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-234.57%
EPS Next 2Y51.34%
EPS Next 3Y45.54%
LYB Yearly Income VS Free CF VS DividendLYB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B

LYB Fundamentals: All Metrics, Ratios and Statistics

LYONDELLBASELL INDU-CL A

NYSE:LYB (3/5/2026, 11:15:09 AM)

66.643

+4.72 (+7.63%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)01-30
Earnings (Next)04-23
Inst Owners71.84%
Inst Owner Change2.66%
Ins Owners0.18%
Ins Owner Change0%
Market Cap21.46B
Revenue(TTM)30.15B
Net Income(TTM)-752.00M
Analysts52.14
Price Target52.2 (-21.67%)
Short Float %7.91%
Short Ratio3.23
Dividend
Industry RankSector Rank
Dividend Yield 4.9%
Yearly Dividend5.46
Dividend Growth(5Y)5.33%
DP-234.57%
Div Incr Years1
Div Non Decr Years1
Ex-Date03-02
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-137.75%
Min EPS beat(2)-299.66%
Max EPS beat(2)24.17%
EPS beat(4)1
Avg EPS beat(4)-80.58%
Min EPS beat(4)-299.66%
Max EPS beat(4)24.17%
EPS beat(8)3
Avg EPS beat(8)-39.32%
EPS beat(12)7
Avg EPS beat(12)-20.1%
EPS beat(16)10
Avg EPS beat(16)-15.37%
Revenue beat(2)2
Avg Revenue beat(2)3.27%
Min Revenue beat(2)3.26%
Max Revenue beat(2)3.27%
Revenue beat(4)4
Avg Revenue beat(4)2.27%
Min Revenue beat(4)0.76%
Max Revenue beat(4)3.27%
Revenue beat(8)7
Avg Revenue beat(8)1.06%
Revenue beat(12)8
Avg Revenue beat(12)0.1%
Revenue beat(16)10
Avg Revenue beat(16)0.24%
PT rev (1m)4.66%
PT rev (3m)-6.07%
EPS NQ rev (1m)-69.14%
EPS NQ rev (3m)-74.89%
EPS NY rev (1m)-16.08%
EPS NY rev (3m)-31.82%
Revenue NQ rev (1m)0.86%
Revenue NQ rev (3m)-0.55%
Revenue NY rev (1m)-0.38%
Revenue NY rev (3m)-1.16%
Valuation
Industry RankSector Rank
PE 39.2
Fwd PE 24.67
P/S 0.71
P/FCF 55.88
P/OCF 9.49
P/B 2.13
P/tB 2.4
EV/EBITDA 13.15
EPS(TTM)1.7
EY2.55%
EPS(NY)2.7
Fwd EY4.05%
FCF(TTM)1.19
FCFY1.79%
OCF(TTM)7.02
OCFY10.54%
SpS93.64
BVpS31.31
TBVpS27.71
PEG (NY)0.67
PEG (5Y)N/A
Graham Number34.61
Profitability
Industry RankSector Rank
ROA -2.21%
ROE -7.46%
ROCE 2.98%
ROIC 2.51%
ROICexc 2.86%
ROICexgc 3%
OM 2.76%
PM (TTM) N/A
GM 8.55%
FCFM 1.27%
ROA(3y)2.42%
ROA(5y)6.64%
ROE(3y)6.57%
ROE(5y)19.56%
ROIC(3y)6.66%
ROIC(5y)11.12%
ROICexc(3y)7.53%
ROICexc(5y)12.09%
ROICexgc(3y)8.19%
ROICexgc(5y)13.23%
ROCE(3y)7.89%
ROCE(5y)13.24%
ROICexgc growth 3Y-44.26%
ROICexgc growth 5Y-15.95%
ROICexc growth 3Y-43.41%
ROICexc growth 5Y-15.05%
OM growth 3Y-35.45%
OM growth 5Y-18.61%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.25%
GM growth 5Y-6.92%
F-Score3
Asset Turnover0.89
Health
Industry RankSector Rank
Debt/Equity 1.22
Debt/FCF 33.69
Debt/EBITDA 5.56
Cap/Depr 135.11%
Cap/Sales 6.23%
Interest Coverage 1.72
Cash Conversion 101.85%
Profit Quality N/A
Current Ratio 1.77
Quick Ratio 1.2
Altman-Z 1.92
F-Score3
WACC7.61%
ROIC/WACC0.33
Cap/Depr(3y)118.58%
Cap/Depr(5y)129.11%
Cap/Sales(3y)5.44%
Cap/Sales(5y)4.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-73.44%
EPS 3Y-48.49%
EPS 5Y-21.44%
EPS Q2Q%-134.67%
EPS Next Y58.88%
EPS Next 2Y51.34%
EPS Next 3Y45.54%
EPS Next 5Y48.11%
Revenue 1Y (TTM)-25.18%
Revenue growth 3Y-15.77%
Revenue growth 5Y1.67%
Sales Q2Q%-25.33%
Revenue Next Year-1.35%
Revenue Next 2Y-0.34%
Revenue Next 3Y0.86%
Revenue Next 5Y-0.68%
EBIT growth 1Y-69.96%
EBIT growth 3Y-45.63%
EBIT growth 5Y-17.24%
EBIT Next Year119.8%
EBIT Next 3Y44.55%
EBIT Next 5Y39.77%
FCF growth 1Y-80.61%
FCF growth 3Y-55.05%
FCF growth 5Y-23.41%
OCF growth 1Y-40.77%
OCF growth 3Y-28.23%
OCF growth 5Y-7.85%

LYONDELLBASELL INDU-CL A / LYB FAQ

Can you provide the ChartMill fundamental rating for LYONDELLBASELL INDU-CL A?

ChartMill assigns a fundamental rating of 3 / 10 to LYB.


What is the valuation status of LYONDELLBASELL INDU-CL A (LYB) stock?

ChartMill assigns a valuation rating of 4 / 10 to LYONDELLBASELL INDU-CL A (LYB). This can be considered as Fairly Valued.


How profitable is LYONDELLBASELL INDU-CL A (LYB) stock?

LYONDELLBASELL INDU-CL A (LYB) has a profitability rating of 3 / 10.


How financially healthy is LYONDELLBASELL INDU-CL A?

The financial health rating of LYONDELLBASELL INDU-CL A (LYB) is 3 / 10.


What is the earnings growth outlook for LYONDELLBASELL INDU-CL A?

The Earnings per Share (EPS) of LYONDELLBASELL INDU-CL A (LYB) is expected to grow by 58.88% in the next year.